Published in Can Respir J on April 27, 2010
Current recommendations for the treatment of mild asthma. J Asthma Allergy (2010) 0.95
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study. NPJ Prim Care Respir Med (2014) 0.83
Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med (2013) 0.83
Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies. J Res Pharm Pract (2013) 0.82
Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach. Front Public Health (2017) 0.75
Economic burden of asthma in Abu Dhabi: a retrospective study. Clinicoecon Outcomes Res (2014) 0.75
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment. BMC Pulm Med (2017) 0.75
Disease Burden of Mild Asthma: Findings from a Cross-Sectional Real-World Survey. Adv Ther (2017) 0.75
The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 13.16
The global burden of asthma. Chest (2006) 5.74
An economic evaluation of asthma in the United States. N Engl J Med (1992) 4.84
Methods for analyzing health care utilization and costs. Annu Rev Public Health (1999) 3.63
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27
Direct and indirect costs of asthma in Canada, 1990. CMAJ (1996) 3.07
A national estimate of the economic costs of asthma. Am J Respir Crit Care Med (1997) 2.97
Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol (2000) 2.48
Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26
A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol (2003) 2.11
Costs of asthma according to the degree of severity. Eur Respir J (1998) 1.78
Asthma severity and medical resource utilisation. Eur Respir J (2004) 1.74
Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol (2001) 1.57
Recent trends in asthma hospitalization and mortality in the United States. J Asthma (2005) 1.39
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ (2001) 1.32
Comparison of Canadian versus American emergency department visits for acute asthma. Can Respir J (2007) 1.23
Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res (2001) 1.13
The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board. Can Respir J (1999) 1.08
Health-care costs of inner-city patients with asthma. J Asthma (1999) 1.07
Compensation for occupational asthma in Quebec. Chest (1990) 1.04
Health care costs associated with acute asthma: a prospective economic analysis. Can Respir J (2000) 0.91
Identifying persons with treated asthma using administrative data via latent class modelling. Health Serv Res (2008) 0.89
Development and validation of database indexes of asthma severity and control. Thorax (2007) 0.88
Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest (2002) 0.87
The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma (2005) 0.86
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet (2003) 5.10
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One (2009) 4.92
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Economic burden of asthma: a systematic review. BMC Pulm Med (2009) 3.10
Spirometry utilization for COPD: how do we measure up? Chest (2007) 2.77
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. Can Respir J (2010) 2.42
Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest (2006) 2.37
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
Empyema: an increasing concern in Canada. Can Respir J (2008) 2.26
Bronchial thermoplasty for asthma. Am J Respir Crit Care Med (2006) 2.15
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Thiazolidinediones and fractures in men and women. Arch Intern Med (2009) 1.98
Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ (2010) 1.95
The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J Crit Care (2010) 1.95
Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics (2009) 1.92
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest (2006) 1.85
Research gaps in protecting healthcare workers from SARS and other respiratory pathogens: an interdisciplinary, multi-stakeholder, evidence-based approach. J Occup Environ Med (2005) 1.70
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study. Eur Respir J (2012) 1.69
Antibiotic use in children is associated with increased risk of asthma. Pediatrics (2009) 1.68
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
Nurse staffing levels and hospital mortality in critical care settings: literature review and meta-analysis. J Adv Nurs (2006) 1.60
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol (2008) 1.59
Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population. Pharmacogenomics (2009) 1.55
Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. Can Respir J (2005) 1.52
Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med (2008) 1.49
Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study. J Allergy Clin Immunol (2013) 1.48
Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest (2009) 1.47
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia (2014) 1.46
Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources? Pediatr Pulmonol (2011) 1.43
Trends and ethnic differences in asthma hospitalization rates in Singapore, 1991 to 1998. Ann Allergy Asthma Immunol (2003) 1.41
De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival. Pediatr Blood Cancer (2014) 1.39
Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials. Pharmacotherapy (2004) 1.39
Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab (2004) 1.38
The "Lost NNT" can be used to represent uncertainty surrounding number needed to treat. J Clin Epidemiol (2012) 1.38
Factors influencing quality of life in patients with active tuberculosis. Health Qual Life Outcomes (2004) 1.35
Health state utilities in latent and active tuberculosis. Value Health (2008) 1.34
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial. PLoS One (2012) 1.30
Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest (2008) 1.29
Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991-2000. BMC Health Serv Res (2005) 1.27
Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J (2011) 1.26
Impact of a health promotion program on employee health risks and work productivity. Am J Health Promot (2007) 1.22
Total costs of IBS: employer and managed care perspective. Am J Manag Care (2005) 1.19
Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Rheum (2007) 1.19
A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada. MedGenMed (2007) 1.18
Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) (2008) 1.15
Perilipin expression in human adipose tissues: effects of severe obesity, gender, and depot. Obes Res (2003) 1.14
Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations. Med Care (2007) 1.14
Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Mol Cell Proteomics (2009) 1.14
Primary care patients reporting concerns about their gambling frequently have other co-occurring lifestyle and mental health issues. BMC Fam Pract (2006) 1.09
Lifestyle screening: development of an acceptable multi-item general practice tool. N Z Med J (2004) 1.07
Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value Health (2013) 1.05
Case finding of lifestyle and mental health disorders in primary care: validation of the 'CHAT' tool. Br J Gen Pract (2008) 1.05
A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction. Chest (2010) 1.04
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD (2012) 1.04
Risk factors associated with habitual snoring and sleep-disordered breathing in a multi-ethnic Asian population: a population-based study. Respir Med (2004) 1.03
Direct detection of bacterial genomic DNA at sub-femtomolar concentrations using single molecule arrays. Anal Chem (2013) 1.02
Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue. Am J Physiol Endocrinol Metab (2006) 1.01
A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol (2011) 0.99
Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children. Ann N Y Acad Sci (2007) 0.98
Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy (2007) 0.97
Patient preferences and experiences of CPAP and oral appliances for the treatment of obstructive sleep apnea: a qualitative analysis. Sleep Breath (2012) 0.97
Reliability studies of diagnostic tests are not using enough observers for robust estimation of interobserver agreement: a simulation study. J Clin Epidemiol (2008) 0.97
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J (2010) 0.96
Variations in the management of acute exacerbations of chronic obstructive pulmonary disease. Can Respir J (2013) 0.96
Current recommendations for the treatment of mild asthma. J Asthma Allergy (2010) 0.95
Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase. J Clin Endocrinol Metab (2006) 0.95
Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. COPD (2013) 0.94
Socioeconomic status and hospital utilization among younger adult pneumonia admissions at a Canadian hospital. BMC Health Serv Res (2006) 0.93
Reconcilable differences: a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting beta-agonist use in asthma. Chest (2004) 0.93
Pharmacogenomics of serious adverse drug reactions in pediatric oncology. J Popul Ther Clin Pharmacol (2011) 0.92
Beta-blocker use and COPD mortality: a systematic review and meta-analysis. BMC Pulm Med (2012) 0.91
Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol (2005) 0.91
A systematic review of economic evaluations of therapy in asthma. J Asthma Allergy (2010) 0.90
An ounce of prevention is worth a pound of cure: a cost-effectiveness analysis of incidentally detected aneurysms in functional MRI research. Value Health (2010) 0.90
The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest (2009) 0.90
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection. J Gen Virol (2012) 0.89
Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity. J Lipid Res (2011) 0.89
A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. PLoS One (2013) 0.89
An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients. Health Qual Life Outcomes (2004) 0.88
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes. Value Health (2010) 0.88
Isoproterenol decreases leptin release from rat and human adipose tissue through posttranscriptional mechanisms. Am J Physiol Endocrinol Metab (2004) 0.87
Comparison of three methods for respiratory virus detection between induced sputum and nasopharyngeal aspirate specimens in acute asthma. J Virol Methods (2002) 0.86
Walking exercise response to bronchodilation in mild COPD: a randomized trial. Respir Med (2012) 0.86
IL-4 receptor genetic polymorphisms and asthma in Asian populations. Respir Med (2006) 0.86
DNA delivery to cells in vivo by ultrasound. Methods Mol Biol (2004) 0.86
Cases: Cocaine adulterant linked to neutropenia. CMAJ (2009) 0.86
Palivizumab for the prevention of respiratory syncytial virus infection. Can Fam Physician (2010) 0.86
Health literacy, language, and ethnicity-related factors in newcomer asthma patients to Canada: a qualitative study. J Immigr Minor Health (2011) 0.85
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Econ (2005) 0.85
Quantifying adverse drug events : are systematic reviews the answer? Drug Saf (2004) 0.85